相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study
Angelo Ruggiero et al.
DERMATOLOGIC THERAPY (2022)
Disturbed expression of vitamin D and retinoic acid-related orphan receptors α and γ and of megalin in inflammatory skin diseases
Anna A. Brozyna et al.
EXPERIMENTAL DERMATOLOGY (2022)
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis
Xing Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study
Matteo Megna et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study
Nahide Onsun et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Increased vascular inflammation on PET/CT in psoriasis and the effects of biologic treatment: systematic review and meta-analyses
N. J. Kleinrensink et al.
CLINICAL AND TRANSLATIONAL IMAGING (2022)
TNF-α blockade may lead to improvement of vascular function in psoriasis patients
Joanna Wegner et al.
EXPERIMENTAL DERMATOLOGY (2022)
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study
Matteo Megna et al.
DERMATOLOGIC THERAPY (2022)
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study
Matteo Megna et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
The Th17 Pathway in Vascular Inflammation: Culprit or Consort?
Marie Robert et al.
FRONTIERS IN IMMUNOLOGY (2022)
Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis
Yan Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis
Christine P. Lin et al.
CURRENT OPINION IN PHARMACOLOGY (2022)
Impact of Interleukin-17 Inhibitor Therapy on Arterial Intima-media Thickness among Severe Psoriatic Patients
Eva Anna Piros et al.
LIFE-BASEL (2021)
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations
A. Nast et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Biomarkers of subclinical atherosclerosis in patients with psoriasis
Hannah Kaiser et al.
SCIENTIFIC REPORTS (2021)
Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Alvaro Gonzalez-Cantero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Psoriasis and Cardiovascular Disease: A Narrative Review
Adrian Martinez-Moreno et al.
KOREAN JOURNAL OF FAMILY MEDICINE (2021)
Analysis of the Potential Genetic Links between Psoriasis and Cardiovascular Risk Factors
Dorota Purzycka-Bohdan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
C-Reactive Protein, Chemerin, Fetuin-A and Osteopontin as Predictors of Cardiovascular Risks in Persons With Psoriasis Vulgaris
Pavel Borsky et al.
PHYSIOLOGICAL RESEARCH (2021)
Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials
Megan Mosca et al.
DERMATOLOGY AND THERAPY (2021)
Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis
George Makavos et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients
S. Gerdes et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis
Amit K. Dey et al.
JAMA DERMATOLOGY (2020)
Do anti-tumour necrosis factor-α biologics affect subclinical measures of atherosclerosis and arteriosclerosis? A systematic review
Laurence Knowles et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Effect of biologics targeting interleukin-23/-17 axis on subclinical atherosclerosis: results of a pilot study
M. Marovt et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
Masahiro Kamata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M. Gelfand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
A. Egeberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
High-sensitivity C-reactive protein as a biomarker in detecting subclinical atherosclerosis in psoriasis
Nasim Niknezhad et al.
DERMATOLOGIC THERAPY (2020)
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
Paolo Gisondi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Recent Advances in Evaluating Impact of Biologic Therapy for Moderate-Severe Psoriasis on Cardiovascular Events and Atherosclerotic Plaque Formation
Justine Dufour et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core Results From a Prospective, Observational Study
Harry Choi et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2020)
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab
Florence Poizeau et al.
JAMA DERMATOLOGY (2020)
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations
A. Nast et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Changes in metabolic parameters in psoriatic patients treated with secukinumab
Hsuan Ning Wang et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study
Youssef A. Elnabawi et al.
CARDIOVASCULAR RESEARCH (2019)
Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index
Youssef A. Elnabawi et al.
JAMA CARDIOLOGY (2019)
Coronary Artery Disease Assessed by Computed Tomography in Patients with Psoriasis: A Systematic Review and Meta-Analysis
Hannah Kaiser et al.
DERMATOLOGY (2019)
Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study
Jacob W. Groenendyk et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks
Esther von Stebut et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers A Randomized Placebo-Controlled Trial
Nehal N. Mehta et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2018)
Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis
S. M. Awad et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2018)
Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis
A. Martinez-Lopez et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders
Agnieszka Owczarczyk-Saczonek et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study
Robert Bissonnette et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Does Treatment of Psoriasis Reduce Cardiovascular Comorbidities?
Mark Lebwohl
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography
Amit K. Dey et al.
JAMA CARDIOLOGY (2017)
Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease
Luca Moroni et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2017)
Correlation between vascular endothelial growth factor and subclinical atherosclerosis in patients with psoriasis
Mohammad Shahidi-Dadras et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis
Stefano Piaserico et al.
ATHEROSCLEROSIS (2016)
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis
Aditya A. Joshi et al.
CIRCULATION RESEARCH (2016)
Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study
Trinitario Pina et al.
JOURNAL OF DERMATOLOGY (2016)
Subclinical cardiovascular disease and it's improvement after long-term TNF- inhibitor therapy in severe psoriatic patients
E. Heredi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Association Between Psoriasis and Subclinical Atherosclerosis A Meta-Analysis
Na Fang et al.
MEDICINE (2016)
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe Psoriasis
Kasper Fjellhaugen Hjuler et al.
JAMA DERMATOLOGY (2016)
Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis
Anna Campanati et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients
A. Pietrzak et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
Gamze Erfan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Bilirubin Levels and Their Association with Carotid Intima Media Thickness and High-Sensitivity C-reactive Protein in Patients with Psoriasis Vulgaris
Sevket Balta et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2014)
Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function
Gunther Marsche et al.
EXPERIMENTAL DERMATOLOGY (2014)
RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D
Andrzej T. Slominski et al.
FASEB JOURNAL (2014)
Evaluation of serum sCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study
Ijlal Erturan et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Platelet activation: a link between psoriasis per se and subclinical atherosclerosis - a case-control study
H. M. A. Saleh et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Increased epicardial fat tissue is a marker of subclinical atherosclerosis in patients with psoriasis
B. Bulbul Sen et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease
I. Balta et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis Results of a Randomized Controlled Trial
Robert Bissonnette et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2013)
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction
Tabassome Simon et al.
EUROPEAN HEART JOURNAL (2013)
Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study
Hajnalka Jokai et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Pathogenic Mechanisms Shared between Psoriasis and Cardiovascular Disease
Ramin Ghazizadeh et al.
International Journal of Medical Sciences (2012)
The concept of psoriasis as a systemic inflammation: implications for disease management
K. Reich
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity
Wolf-Henning Boehncke et al.
EXPERIMENTAL DERMATOLOGY (2011)
Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
Georgia Avgerinou et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis
Jurate Garbaraviciene et al.
EXPERIMENTAL DERMATOLOGY (2010)
Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis
Yoichi Inaba et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2010)
A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice
Qi Gao et al.
JOURNAL OF IMMUNOLOGY (2010)
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Chronic Plaque Psoriasis Is Associated with Increased Arterial Stiffness
Paolo Gisondi et al.
DERMATOLOGY (2009)
Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis
D. D. Balci et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors
Carlos Gonzalez-Juanatey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
